BioSpace News Archive

Drug Development

Corvus Pharmaceuticals Announces Publication of Preclinical Data Demonstrating Potential of ITK Inhibition with Soquelitinib as a Novel Approach to T Cell-Mediated Inflammatory and Immune Diseases

Corvus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced the publication of preclinical data that demonstrated the potential of ITK inhibition as a novel approach to treat T cell-mediated inflammatory and immune diseases.

November 1, 2023
·
9 min read
Pharm Country

UZEDY™ (risperidone) Extended-Release Injectable Suspension Significantly Prolongs Time to Schizophrenia Relapse in RISE Study Results Published in The Lancet Psychiatry

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., announced the publication of efficacy and safety findings from the phase 3 Risperidone Subcutaneous Extended-Release study in The Lancet Psychiatry.

November 1, 2023
·
19 min read
Drug Development

Kodiak Sciences Announces First Time Presentation of Primary Endpoint Data From Tarcocimab Tedromer Phase 3 GLOW Study in Patients With Diabetic Retinopathy at American Academy of Ophthalmology Annual Meeting

Kodiak Sciences Inc announced that data from tarcocimab tedromer will be presented during the annual meeting of the American Academy of Ophthalmology to be held November 3-6 in San Francisco.

November 1, 2023
·
4 min read